SANGAMO THERAPEUTICS, INC
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 501 CANAL BLVD., RICHMOND, CA, 94084
Mailing Address 501 CANAL BLVD., RICHMOND, CA, 94084
Phone 5109706000
Fiscal Year End 1231
EIN 680359556
Financial Overview
FY2025
-$122.93M
Net Income
$101.64M
Total Assets
$78.86M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 424B5 Prospectus supplement | February 4, 2026 | View on SEC |
| 8-K Current report of material events | February 4, 2026 | View on SEC |
| 8-K Current report of material events | February 3, 2026 | View on SEC |
Annual Reports
10-K March 30, 2026
- Lead drug candidate isaralgagene civaparvovec (ST-920) for Fabry disease has completed Phase 1/2 clinical trials.
- Active regulatory discussions with the FDA are underway to define the approval pathway for their lead program.
Material Events
8-K Strategy Change March 30, 2026
High Impact
- Strategic pivot to a neurology-focused biotech model
- Advancement of ST-920 for Fabry disease into late-stage testing
Related Companies
Companies in the same industry (SIC: 2836)
Zivo Bioscience, Inc.
ZIVO Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX Biological Products, (No Diagnostic Substances)
EXOZYMES INC.
EXOZ Biological Products, (No Diagnostic Substances)
Aura Biosciences, Inc.
AURA Biological Products, (No Diagnostic Substances)
Jasper Therapeutics, Inc.
JSPR Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.